Comments
Loading...
Sage Therapeutics (SAGE) Forecast
NewsEarningsSage Therapeutics (SAGE) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestSage Therapeutics (NASDAQ:SAGE) Stock Quotes, Forecast and News Summary
Sage Therapeutics Stock (NASDAQ: SAGE) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Sage Therapeutics (SAGE) stock?
You can purchase shares of Sage Therapeutics (NASDAQ:SAGE) through any online brokerage.
Who are Sage Therapeutics (SAGE) competitors?
Other companies in Sage Therapeutics’s space includes: Humacyte (NASDAQ:HUMA), Upstream Bio (NASDAQ:UPB), Altimmune (NASDAQ:ALT), PureTech Health (NASDAQ:PRTC) and Monte Rosa Therapeutics (NASDAQ:GLUE).
What is the forecast, or price target, for Sage Therapeutics (SAGE) stock?
Sage Therapeutics has a consensus price target of $13.33.
What is the current price for Sage Therapeutics (SAGE)?
The stock price for Sage Therapeutics (NASDAQ: SAGE) is $7.26 last updated February 21, 2025 at 9:30 AM EST.
Does Sage Therapeutics (SAGE) pay a dividend?
There are no upcoming dividends for Sage Therapeutics.
When is Sage Therapeutics (NASDAQ:SAGE) reporting earnings?
Sage Therapeutics’s Q1 earnings are confirmed for Thursday, April 24, 2025.
Is Sage Therapeutics (SAGE) going to split?
There is no upcoming split for Sage Therapeutics.
What sector and industry does Sage Therapeutics (SAGE) operate in?
Sage Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.